Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
It's becoming Hengrui Pharma's world, and some Western drugmakers are just living in it. China's largest pharma company, which boasts one of the biggest pipelines in the industry, has lined up Bristol Myers Squibb as ...
May 12, 2026 05:06 AM EDT DealsChinaPharma Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B Kyle LaHucik Biotech Correspondent It’s becoming Hengrui Pharma’s world, and some Western drugmakers are just living in it. China’s largest pharma company, which boasts one of the biggest pipelines … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that